Skip to main content
Premium Trial:

Request an Annual Quote

EOS Biotechnology, Incyte Genomics, Surmodics

Premium

EOS Biotechnology of South San Francisco received US Patent No. 6,516,276, “Method and apparatus for analysis of data from biomolecular arrays.” The patent covers an application for analyzing data from biomolecular binding experiments that collects data from probes and generates probability values on bindng success. Normalized values are generated and data is ouput incuding normalized values and probablility values for the array probe sets.

Incyte Genomics of Palo Alto, Calif., received US Patent No. 6,514,751, “Linear microarrays.” The patent provides a method for detecting the presence of polynucleotide sequence in a sample. The system uses volumes in the range of 10 nanoliters to 10 microliters for sample delivery, hybridization, or washes. It is constructed of capillary-like casings, with input and output openings, and a substrate immobilized in each of the casings.

Surmodics of Eden Prairie, Minn., received US Patent No. 6,514,768, “Replicable probe array.” The patent covers a system for producing nucleic acid-based arrays by replicating an original master array, or providing a reusable assay capable of being regenerated.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.